Stereotactic radiosurgery in patients with small cell lung cancer and 1-10 brain metastases: A multi-institutional, phase II, prospective clinical trial.
Ayal A. Aizer(Brigham and Women's Hospital), Shyam Tanguturi(Harvard University), Lauren Hertan(University of Pennsylvania), Jack M. Qian(South Shore Hospital), R. Shiloh(Brigham and Women's Hospital), Wenya Linda Bi(Broad Institute), Rifaquat Rahman(Brigham and Women's Hospital), Jacob Sands(Harvard University), Raymond H. Mak(Twitter (United States)), Paul J. Catalano(Computational Physics (United States)), David Kozono(Brigham and Women's Hospital), Itai Pashtan(Brigham and Women's Hospital), Fallon Chipidza(Brigham and Women's Hospital), Daphne A. Haas‐Kogan(Brigham and Women's Hospital), Luke Peng(Dana-Farber Brigham Cancer Center), Monica Krishnan(Brigham and Women's Hospital), Ivy Ricca(Brigham and Women's Hospital), Kee‐Young Shin(Dana-Farber Cancer Institute)
Cited by 8
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
|New England Journal of Medicine|2012|1.1k
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|459
Integrated genomic characterization of endometrial carcinoma
|Carolina Digital Repository (University of North Carolina at Chapel Hill)|2013|415